- Home
- SFST vs BLDE Comparison
SFST vs BLDE Comparison
Compare SFST & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- BLDE
- Stock Information
- Founded
- SFST 1999
- BLDE 2014
- Country
- SFST United States
- BLDE United States
- Employees
- SFST N/A
- BLDE N/A
- Industry
- SFST Major Banks
- BLDE Aerospace
- Sector
- SFST Finance
- BLDE Consumer Discretionary
- Exchange
- SFST Nasdaq
- BLDE Nasdaq
- Market Cap
- SFST N/A
- BLDE 257.2M
- IPO Year
- SFST 1999
- BLDE N/A
- Fundamental
- Price
- SFST $33.39
- BLDE $3.27
- Analyst Decision
- SFST Buy
- BLDE
- Analyst Count
- SFST 1
- BLDE 0
- Target Price
- SFST $44.00
- BLDE N/A
- AVG Volume (30 Days)
- SFST 21.3K
- BLDE 484.5K
- Earning Date
- SFST 10-17-2024
- BLDE 11-06-2024
- Dividend Yield
- SFST N/A
- BLDE N/A
- EPS Growth
- SFST N/A
- BLDE N/A
- EPS
- SFST 1.70
- BLDE N/A
- Revenue
- SFST $88,995,000.00
- BLDE $238,379,000.00
- Revenue This Year
- SFST N/A
- BLDE $12.14
- Revenue Next Year
- SFST $13.55
- BLDE $11.35
- P/E Ratio
- SFST $19.58
- BLDE N/A
- Revenue Growth
- SFST N/A
- BLDE 25.39
- 52 Week Low
- SFST $24.98
- BLDE $2.06
- 52 Week High
- SFST $39.36
- BLDE $4.25
- Technical
- Relative Strength Index (RSI)
- SFST 54.81
- BLDE 57.45
- Support Level
- SFST $33.26
- BLDE $2.86
- Resistance Level
- SFST $34.53
- BLDE $3.33
- Average True Range (ATR)
- SFST 0.86
- BLDE 0.16
- MACD
- SFST -0.01
- BLDE 0.02
- Stochastic Oscillator
- SFST 37.36
- BLDE 84.40
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.